[{"Assets_0_Q1_USD":"1572091000.0","CIK":"874716","CommonStockSharesIssued_0_Q1_shares":"103740000.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.78","EarningsPerShareDiluted_1_Q1_USD":"0.77","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"42180715521.0","MinorityInterest_0_Q1_USD":"178000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"31274000.0","NetIncomeLoss_1_Q1_USD":"69019000.0","OfficialName":"IDEXX Laboratories Inc. Common Stock","ProfitLoss_1_Q1_USD":"69058000.0","RevenuesConverted_1_Q1_USD":"462021000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":"-73912000.0","StockholdersEquity_0_Q1_USD":"-74090000.0","Ticker":"IDXX","TreasuryStockSharesConverted_0_Q1_shares":"15807000.0","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"89994000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"88117000.0","filed":"20170428","footnote":null,"form":"10-Q","fp":"Q1","fy":"2017.0","name":"IDEXX LABORATORIES INC \/DE","period":"20170331","qtrs":"0","uom":"USD"}]